We are thrilled to announce that the Rheumatology Society of Ghana (RSG), in partnership with the African League Against Rheumatism ( AFLAR ), will officially host the AFLAR 2027 Congress in the vibrant city of Accra. Under the inspiring theme "Innovate, Integrate, Impact: Shaping the Future of Rheumatology in Africa," this premier continental meeting marks a historic milestone for the Ghanaian medical community and the broader West African healthcare landscape. AFLAR 2027 is designed to be a transformative experience for the 500 to 800+ delegates expected to arrive from across the globe. The three-day scientific programme is meticulously structured to address the unique challenges and opportunities within African healthcare: Day 1: Innovate – Highlighting cutting-edge research, new diagnostic technologies, and the latest pharmaceutical advancements in autoimmune care. Day 2: Integrate – Focusing on multidisciplinary care models, bridging the gap between primary care and specialists, and strengthening healthcare infrastructure. Day 3: Impact – Dedicated to translating science into improved patient outcomes, public policy changes, and sustainable access to care. The significance of hosting this event in Ghana cannot be overstated. It provides a rare localized platform for our domestic healthcare workers to engage with international standards of care while showcasing the resilience and ingenuity of African clinical practice. By bringing the global rheumatology community to our doorstep, we are fostering a spirit of collaboration that will outlast the three-day event. This congress serves as a catalyst for future research partnerships and provides a global stage for our local researchers to present findings that are specifically relevant to our unique genetic and environmental landscape. Accra, known for its warm hospitality, rich cultural heritage, and modern amenities, serves as the perfect backdrop for this exchange of knowledge. We invite you to join us in shaping the future of African rheumatology. Beyond the lecture halls, the congress will offer cultural tours and gala events designed to strengthen the bonds between delegates. Keep an eye on our Communications hub for upcoming details regarding abstract submission portals, early-bird registration, and partnership packages. Together, let us innovate for a healthier Africa.
As the Rheumatology Society of Ghana (RSG) continues to expand its reach, it is essential to address the broader systemic challenges that impact the delivery of care for rheumatic and musculoskeletal diseases (RMDs) across our nation. While our clinical expertise is growing, the path to comprehensive care for the average Ghanaian patient remains hindered by several "general issues" that require urgent attention from policymakers, healthcare administrators, and the public alike. One of the most pressing concerns is the high cost of long-term care. Rheumatic conditions are, by definition, chronic. Unlike an acute infection that can be cleared with a single course of antibiotics, conditions like Rheumatoid Arthritis or Psoriatic Arthritis require life-long medication and monitoring. For many in our community, the financial burden of monthly prescriptions, frequent laboratory tests, and specialized imaging like musculoskeletal ultrasounds is overwhelming. When these costs are not fully covered by insurance, patients are often forced to choose between their health and their daily livelihood, leading to "medical non-compliance" that isn't a choice, but a financial necessity. Furthermore, there is a significant geographical disparity in access to specialized care. Currently, the majority of Ghana’s rheumatology resources are concentrated in major urban hubs like Accra and Kumasi. For a patient living in the northern regions or rural outskirts, a single follow-up appointment can involve a full day of travel and significant transportation costs. This "distance barrier" often leads to lost follow-ups, allowing manageable conditions to flare into debilitating crises. To address these hurdles, the RSG is advocating for a more integrated healthcare model. We are calling for: Wider Insurance Coverage : Incorporating more specialized DMARDs (Disease-Modifying Anti-Rheumatic Drugs) and diagnostic tests into the National Health Insurance Scheme. Telemedicine Initiatives : Leveraging digital health to provide remote consultations for stable patients in underserved areas. Primary Care Training : Equipping general practitioners and nurses across all ten regions with the skills to recognize early warning signs and manage basic maintenance therapy. The burden of RMDs is not just a medical issue; it is a socio-economic one. When a young breadwinner is sidelined by chronic pain, the entire family unit suffers. By addressing these systemic gaps, we aren't just treating joints—we are protecting the productivity and well-being of our nation. We invite our partners and stakeholders to explore our Advocacy page to see how we are working to make rheumatology care accessible to every Ghanaian, regardless of their location or income. Together, we can build a healthcare system that truly leaves no one behind.
Gout is frequently dismissed as a "disease of kings" or a simple consequence of overindulgence, but for thousands of Ghanaians, it is a debilitating chronic condition that requires serious medical management. As urbanization increases and dietary habits shift across West Africa, the Rheumatology Society of Ghana has observed a sharp rise in gout cases, making it one of the most common reasons for rheumatology consultations in our clinics. A common myth is that gout is merely a temporary flare-up caused by one "bad meal." In reality, gout is a form of inflammatory arthritis caused by an accumulation of urate crystals in the joints. Without proper long-term management, frequent attacks can lead to permanent joint destruction and "tophi"—visible lumps under the skin that can become infected or ulcerated. Furthermore, untreated gout is often linked to other serious health issues, including hypertension, kidney disease, and cardiovascular problems. It is a systemic issue that impacts the entire body, not just the "angry" joint that hurts during a flare. In Ghana, many patients attempt to manage joint swelling with over-the-counter painkillers or herbal remedies. While these may provide temporary relief, they do not address the underlying high levels of uric acid in the blood. Our goal at the RSG is to promote a "Treat-to-Target" approach, where medication is used not just to stop the pain of a flare, but to lower uric acid levels permanently, preventing future attacks altogether. We must move away from reactive medicine and toward proactive, lifelong management to prevent the long-term disability that chronic gout can cause. Dietary modifications—such as reducing the intake of organ meats, sugary sodas, and certain alcohols—are important, but for most patients, they are only one piece of the puzzle. Genetics and kidney function play a much larger role than most people realize. It is unfair to place the entire burden of the disease on a patient's lifestyle choices when their body simply cannot process uric acid efficiently. Through our Education subpages, we provide resources for both patients and clinicians on the latest evidence-based guidelines for gout management. We encourage anyone experiencing sudden, intense pain in the big toe or other joints to seek a professional evaluation. Knowledge is the first step toward a pain-free life.